Novavax, COVID-19
Opinion
Why Novavax is Gaining Ground in COVID-19 Vaccine Race
COVID-19 Positive Rate Spikes With more knowledge about the virus, ample funding, and new treatments, the worst of the COVID-19 pandemic seems to be behind us (from a death perspective). However, just because the Coronavirus death rate has dropped dramatically since its major peak in 2020 (and a subsequent spike in 2021) doesn’t mean that COVID-19 is still not negatively impacting people who get it.
Novavax or Nothing? For Some, It’s Their COVID Vaccine Choice
For many, Novavax is #1 – the one and only COVID vaccine they would consider. This enthusiasm for Novavax isn’t new. As far back as 2022, news reports described a kind of Novavax fan club – a term that irritates some – and it’s still here.
Novavax 2024-2025 Formula COVID-19 Vaccine Available at Major Pharmacies Across the U.S.
Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced that doses of the Novavax COVID-19 Vaccine, Adjuvanted (2024-2025 Formula) (NVX-CoV2705) to prevent COVID-19 in individuals aged 12 and older are in stock at major pharmacy retailers across the U.
Novavax Says Its COVID-19 Vaccine 2024-2025 Formula Now Available At Major Pharmacies Nationwide
Novavax, Inc. (NVAX) announced Friday that doses of the Novavax COVID-19 Vaccine, Adjuvanted (2024-2025 Formula) (NVX-CoV2705) to
Updated Novavax COVID-19 vaccines could be available as early as next week
The FDA authorized an updated version of the protein-based Novavax COVID-19 vaccine for use in people 12 and up. Doses could be available by next week.
FDA Approves Novavax's Updated COVID Vaccine Targeting Currently Circulating Variants
The FDA granted Emergency Use Authorization to Novavax's updated COVID-19 vaccine for individuals aged 12 and older. The vaccine, included in CDC recommendations, will soon be available nationwide. Novavax's shot targets the JN.
Free updated Covid-19 vaccines given out by Springfield Pharmacy to help slow the spread
As COVID-19 cases continue to rise, the distribution of a newly released FDA approved vaccine is brining hope to residents of Springfield. 22News has a closer look at this updated vaccine, and how the city is trying to slow the spread.
Updated COVID-19 Vaccine Available
The latest COVID-19 vaccines have been approved by the federal government and are being shipped to pharmacies, New York State announced on Sept. 4. The federal Centers for Disease Control and Prevention recommends the 2024-25 vaccines from Pfizer,
Novavax Inc. stock underperforms Wednesday when compared to competitors
Shares of Novavax Inc. NVAX slid 2.86% to $12.56 Wednesday, on what proved to be an all-around dismal trading session for the ...
Could This Be the Catalyst Novavax Needs to Get Its Stock Rallying Again?
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
$1000 Invested In Novavax 5 Years Ago Would Be Worth This Much Today
Buying $1000 In NVAX: If an investor had bought $1000 of NVAX stock 5 years ago, it would be worth $2,000.00 today based on a ...
BioSpace16d
Novavax Catches Up to Competitors With FDA Approval for Updated COVID-19 Boosters
Unlike Pfizer/BioNTech and Moderna, Novavax does not use mRNA technology for its COVID-19 vaccine, instead opting for a ...
Should You Buy Novavax Stock After This Regulatory Win?
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
Novavax Inc. stock underperforms Tuesday when compared to competitors
Shares of Novavax Inc. NVAX slid 2.05% to $12.93 Tuesday, on what proved to be an all-around mixed trading session for the ...
Why Are Novavax Shares Trading Lower Today?
Novavax Inc. (NASDAQ: NVAX) shares are trading lower Thursday following multiple significant announcements. Here's what you need to know.
bovnews6d
Novavax Inc (NVAX) Stock: Greater Than Its Current Valuation?
Novavax Inc (NVAX) stock saw a decline, ending the day at $11.92 which represents a decrease of $-0.37 or -3.01% from the prior close of $12.29. The stock opened at $11.75 and touched a low of $11.09 ...